Background-Mice are well suited for modeling human congenital heart disease (CHD), given their 4-chamber cardiac anatomy. However, mice with CHD invariably die prenatally/neonatally, causing CHD phenotypes to be missed. Therefore, we investigated the efficacy of noninvasive microcomputed tomography (micro-CT) to screen for CHD in stillborn/fetal mice. These studies were performed using chemically mutagenized mice expected to be enriched for birth defects, including CHD. Methods and Results-Stillborn/fetal mice obtained from the breeding of N-ethyl-N-nitrosourea mutagenized mice were formalin-fixed and stained with iodine, then micro-CT scanned. Those diagnosed with CHD and some CHD-negative pups were necropsied. A subset of these were further analyzed by histopathology to confirm the CHD/no-CHD diagnosis.
C ongenital heart disease (CHD) is one of the most common birth defects and, during the past decade, mice have become the model system of choice for studying CHD. 1 Thus, mice have similar cardiovascular anatomy as humans, both exhibiting a 4-chamber heart with separate pulmonary/ systemic circulation that are the major substrates for CHD. However, CHD diagnosis in mice is challenging, given mice with structural heart defects invariably die prenatally or neonatally. 2 Also because of the very small size of the fetal/ newborn mouse heart, the requisite necropsy and histopathology examination required for CHD diagnosis is difficult. Therefore, in the current era of functional genomics, improved high-throughput phenotyping with proven efficacy is necessary to allow for complete annotation of the mammalian genome, such as in the analysis of knockout and mutant mice being generated in mutagenesis screens or through knockout mouse production in KOMP/KOMP2. 3, 4 
Clinical Perspective on p 559
Microcomputed tomography (micro-CT) is an attractive imaging modality for high-throughput fetal/neonatal phenotyping of structural heart defects in mice, especially when this is combined with the use of iodine-based reagent for contrast enhancement. [5] [6] [7] This nondestructive imaging method can provide isotropic resolutions as high as 5 to 10 μm, with 1 study showing feasibility in identifying outflow tract (OFT) septation defects and aortic arch anomalies in newborn mice. 5 However, the spectrum of structural heart defects that can be detected in newborn mice by contrast-enhanced micro-CT imaging and its detection sensitivity and accuracy have not been evaluated. Furthermore, the feasibility of phenotyping fetal mice by micro-CT imaging has not been examined.
In this study, we evaluated the spectrum of CHD that can be detected by micro-CT imaging in neonatal and fetal mice using animals generated from an N-ethyl-N-nitrosourea mutagenized mouse colony. This provided an ideal context to assess the efficacy of micro-CT imaging for CHD diagnosis because this population of mice is expected to be enriched for mutants with CHD. 8 
Methods

Sample Preparation
C57BL6/J N-ethyl-N-nitrosourea mutagenized mice were bred for recessive mutations in a 2-generation backcross breeding scheme as described previously. 8, 9 G3 fetuses/pups were fixed in 10% formalin for 48 hours before iodine-staining for micro-CT imaging. After washing twice with distilled water, iodine-staining was performed using a solution of 25% Lugol 5 with 5% of iodine metal (Sigma-Aldrich). Samples were stained for 48 to 72 hours, micro-CT scanned, and returned to 10% formalin to destain for necropsy and histological analysis. All animal studies were approved by the Institutional Animal Care and Use Committee of the University of Pittsburgh.
Micro-CT Scanning
Mouse fetuses/pups were placed in a custom cradle accommodating 12 neonates, and scanned using the Siemens Inveon Multimodality micro-CT scanner (Siemens Medical Solutions Inc, Knoxville, TN) set to 80 kVp/100 μA, and 500 to 800 milliseconds exposure. The detector and X-ray source were rotated 220° in 1-degree steps, calibration exposures configured to 30, and the field-of-view set at maximum voxel size of 50×50×50 mm. 3 Neonates were scanned at 45 μm resolution (45×45×45 μm/voxel), whereas fetuses were scanned at 15 μm (15×15×15 μm/voxel). CT data were DICOM converted and examined using OsiriX DICOM Viewer (Version 3.8.1; the OsiriX Foundation, Geneva, Switzerland). Typically coronal (anteroposterior), transverse (cross-section), and sagittal views were generated for CHD diagnosis.
Necropsy and Histopathology Assessments
Fetuses/pups determined to have CHD were further evaluated by necropsy and histopathology to confirm the micro-CT-assessed CHD diagnosis. Necropsy was performed using a stereomicroscope to examine detailed cardiovascular anatomy. For samples suspected to have structural heart defects, the heart/lung was paraffin embedded, and sectioned using an SM2500 sledge microtome and imaged using episcopic fluorescence image capture (EFIC) as previously described. 10 EFIC provides serial 2-dimensional serial image stacks that are in perfect registration similar to micro-CT/micro-MRI data sets. 10, 11 As a result, the serial digital images collected can be digitally resectioned in any imaging plane or reconstructed in 3-dimension using Osirix or Volocity (Perkin Elmer, Branford, CT). This allowed a full assessment of intracradiac anatomy for CHD diagnosis in every specimen. This same EFIC imaging analysis was performed for a subset of pups determined not to have CHD based on the micro-CT imaging analysis. This was performed to estimate the false-negative rate for micro-CT diagnosis of CHD.
Intraobserver and Interobserver Variability
To determine the intraobserver and interobserver variability in micro-CT diagnosis, a pediatric cardiologist and pathologist assistant who performed most of the micro-CT diagnosis reanalyzed the micro-CT data for 84 pups. This was performed ≈6 to 10 months from the original date of diagnosis. The evaluators were blinded with respect to the other individual's diagnoses, and to their own previous diagnosis. The data generated from this reassessment were used to calculate the interobserver and intraobserver variability, and the κ coefficient was calculated to assess intraobserver (comparison of diagnoses made at 2 different time points by the same evaluator) and interobserver (comparison of diagnoses made by 2 different evaluators) variability. The strengths of intraobserver and interobserver agreement were defined by the following κ coefficient values: almost perfect (≥0.80), substantial (0.60-0.79), moderate (0.40-0.59), fair (0.20-0.39), and poor (<0.20) intraobserver and interobserver agreement. 12
Specificity, Sensitivity, and Accuracy of Micro-CT Imaging
The specificity and sensitivity of micro-CT imaging in identifying each specific CHD were calculated as follows. The sensitivity corresponded to the number of confirmed CHD diagnosis divided by the number of confirmed plus missed CHD (erroneous no-CHD) diagnoses as determined by histopathologic analysis. It provided an assessment of the efficacy of micro-CT in correctly identifying CHD. Specificity is calculated as the number of confirmed no-CHD diagnoses divided by the number of confirmed no-CHD plus erroneous no-CHD diagnoses. It provided an estimate of the efficacy of micro-CT in not misidentifying normal no-CHD samples as having CHD. The overall accuracy is calculated by summing the number of confirmed CHD and no-CHD diagnoses identified by micro-CT for each specific defect divided by the total micro-CT scanned fetuses/neonates.
Results
We performed micro-CT scans of 2105 mice generated from an N-ethyl-N-nitrosourea mutagenesis colony, comprising 1968 newborn pups and 137 mid-to late-term fetuses (E14.5 to E17.5). Micro-CT scanning was performed at 45-μm resolution for neonates, and 15-μm resolution for fetal mice. These resolutions were determined to be sufficient for visualizing all of the major cardiovascular anatomy in the fetal and neonatal mouse. From this analysis, we identified 380 pups (19.3%) and 41 fetuses (29.9%) with structural heart defects ( Table 1) .
All of the fetuses/pups with CHD were necropsied and, for 160 samples (18 fetuses/142 neonates), EFIC histopathology was performed to confirm the structural heart defect diagnosis. EFIC is a high-resolution histological imaging technique (0.1×0.1×0.1 μm/voxel) that streamlines structural heart defect assessment by allowing visualization of intracardiac anatomy in 3 dimensions (see Methods) and was used as the gold standard for CHD diagnosis in this study. In parallel, we also performed necropsy and EFIC histopathology examination of 114 fetuses/pups identified by micro-CT as CHD negative. These were selected from litters in which other fetuses/pups had been identified with CHD.
Statistical power calculations showed that the combined 274 CHD positive/CHD negative samples were more than adequate for ventricular septal defect (VSD) assessment given its high prevalence (0.146; Table 1 ). Thus for VSD, only 62 samples are required to achieve 93% power at 5% significance level for detecting a change in sensitivity from 0.5 to 0.95 using a 2-sided binomial test. Similar power was not achieved for other CHD with lower prevalence because many more samples would be required, 526 for double outlet right ventricle (DORV; prevalence of 0.0171; Table 1 ) and 1184 for coronary fistulas (prevalence of 0.0076; Table 1 ).
The overall reproducibility of the micro-CT assessments was also evaluated with analysis of interobserver and intraobserver variability 12 using κ coefficients calculated based on CHD diagnosis obtained by EFIC histopathology. This showed micro-CT interobserver variability of 0.90, whereas intraobserver variability was 0.88. These results showed that overall micro-CT diagnostic reproducibility was excellent.
Micro-CT Detection of VSDs
The most prevalent structural heart defect detected consisted of VSDs (n=307), corresponding to 14.6% of mice that were micro-CT scanned ( Figure 1 ; Table 1 ). This included 189 perimembranous VSDs (9%; Figure 1A and 1C) and 120 muscular VSDs (5.7%; Figure 1B and 1D), 12 of which had both perimembranous and muscular VSDs. The incidence of VSDs was similar in neonates (14.5%) and fetuses (16.1%; Table 1 ). The efficacy of micro-CT in VSD diagnosis was evaluated by EFIC histopathology examination. Of the 274 samples analyzed by EFIC imaging (160 diagnosed by micro-CT as CHD positive and 114 CHD negative), 84 had VSDs. This comprises 72 samples that were micro-CT diagnosed and 12 samples with VSD missed by micro-CT (9 with perimembranous, 3 with small muscular VSD). Of the 160 micro-CT diagnosed VSD samples, 16 were found to be normal. Together, these findings show that micro-CT has a VSD detection sensitivity of 85.7%, specificity of 91.6%, and accuracy of 89.8% (see Methods).
Micro-CT Detection of Aortic Arch Anomalies
Micro-CT imaging readily detected aortic arch anomalies ( Figure 2 ), including right aortic arch (RAA), interrupted aortic arch (IAA), and coarctation (CoA). Because the narrowed portion of the aorta was often difficult to visualize ( Figure 2H , 2H′, 2P, and 2P′), CoA and IAA were combined into 1 defect category ( Figure 2G , 2K, 2O, and 2S; Table 1 ). Micro-CT identified aortic arch defects in 38 fetuses/pups (1.9%), with 28 RAA and 12 IAA/CoA. This included 2 animals exhibiting both RAA and IAA/CoA (Table 1 ). Among the 9 fetuses identified with arch anomalies, 7 exhibited RAA and 2 had IAA/ CoA. All of the aortic arch anomalies identified by micro-CT were confirmed by necropsy, with 21 further validated by EFIC imaging. Of the latter, 15 had RAA, and 6 showed IAA or CoA. Of the remaining fetuses/pups analyzed by EFIC histopathology, only 1 had an aortic arch anomaly that was missed, a preductal CoA. Together, this yielded a sensitivity of 95.5%, specificity of 100%, and overall accuracy of 99.6% ( Table 2) .
Micro-CT Detection of OFT Anomalies
Micro-CT imaging indicated 53 (2.5%) fetuses/pups had OFT anomalies, including DORV, transposition of the great arteries, and persistent truncus arteriosus (Figure 3 ). Thirteen of the 55 samples were fetuses. Shown in Figure 4 is an E15.5 fetus micro-CT diagnosed with DORV, hypoplastic pulmonary artery, stenotic pulmonary valve, and a large VSD (Figure 4A , 4D, and 4F). All the diagnoses in this fetus were confirmed by EFIC histopathology (Figure 4E and 4G ). Three-dimensional rendering of EFIC or micro-CT imaging data showed that the VSD was part of an atrioventricular septal defect (AVSD; Figure 4B and 4C; Videos I and II in the online-only Data Supplement).
Overall, micro-CT imaging identified 36 animals with DORV, 14 with transposition of the great arteries, and 3 with persistent truncus arteriosus. EFIC analysis confirmed the OFT CT-diagnosis in 31 of 36 samples, whereas among the other EFIC analyzed specimen, there were 6 shown to have OFT anomalies that were missed by micro-CT, 2 from the 160 CHD positive and 4 from the 114 CHD-negative micro-CT analyzed samples. This yielded a sensitivity of 86.1% and specificity of 99.2%, and an overall accuracy of 97.4% (Table 2 ). It should be noted that 9 of the 13 fetuses with micro-CT diagnosis of OFT anomalies were EFIC analyzed and, in all 9 cases, their CHD diagnosis were confirmed. This demonstrates the efficacy of micro-CT in detecting OFT anomalies in fetal mice.
Micro-CT Detection of Other Cardiac Anomalies
Micro-CT imaging identified other structural heart anomalies, including coronary artery fistulas, AVSD, and tricuspid valve hypoplasia/atresia. Coronary artery fistulas were detected with micro-CT imaging in 16 fetuses/neonates ( Figure 5 ). EFIC imaging analysis in 6 of these animals confirmed 5 had coronary artery fistulas. EFIC analysis of the other 268 animals revealed another 5 with coronary artery fistulas missed by micro-CT (Table 2 ). This included 1 found among the 114 CHD-negative micro-CT analyzed samples. Together, this yielded a detection sensitivity of 50.0%, specificity of 99.6%, and accuracy of 97.8% (Table 2 ). AVSD was found in 22 samples by micro-CT, and EFIC histopathology on 16 confirmed the diagnosis in 14 specimens. Of the remaining EFIC analyzed samples, only 1 AVSD was identified that was missed by micro-CT. Together, this yielded a sensitivity of 87.5%, specificity of 99.6%, and an overall accuracy of 97.8% for AVSD ( Table 2 ). Tricuspid valve hypoplasia/ atresia was found in 13 animals and was based primarily on a marked reduction in the size of the right ventricle ( Figure 6A and 6D) . EFIC histopathology confirmed the hypoplastic right ventricle and also identified hypoplastic tricuspid valves, thereby affirming the diagnosis of tricuspid hypoplasia/atresia in 3 neonates and 1 fetus ( Figure 6B , 6C, 6E, and 6F) for a 100% accuracy overall. 
Micro-CT Detection of Complex CHD Associated With Heterotaxy
Another cardiac anomaly readily detected by micro-CT was dextrocardia (Table 1 ). This was found in 4 newborn pups, all of which were confirmed by necropsy, with no additional dextrocardia found in the remaining 270 samples analyzed by necropsy and EFIC imaging (Figure 7) . Dextrocardia was associated with complete mirror symmetrical reversal of visceral organ situs (situs inversus totalis; Figure 7B , 7E, and 7H) or left-right randomized visceral organ situs (heterotaxy; Figure 7C, 7F, and 7I ). Heterotaxy is of particular interest given complex CHD is often found in patients with heterotaxy. This was also observed in mice. Shown in Figure 8 is a neonate identified with dextrocardia by micro-CT. It exhibited bilateral single lung lobes, indicating left-pulmonary isomerism. Both OFTs emerged from the left-sided morphological right ventricle, indicating DORV ( Figure 8D and 8F) . Also observed were hypoplastic RAA ( Figure 8A and 8D) , atrial septal defect, and muscular VSD ( Figure 8B and 8E ). All of these structural heart defects were confirmed by EFIC histopathology (Figure 8C, 8G, 8H, and 8I) . Although dual superior vena cavae were observed by micro-CT and necropsy, suggesting right atrial isomerism ( Figure 8A and 8B) , EFIC imaging revealed 2 coronary sinuses, normally a left-sided structure, thus indicating atrial situs ambiguous (data not shown). These findings show the efficacy of micro-CT imaging in the detection of complex structural heart defects in fetal/newborn mice.
Discussion
Analysis of 2105 fetal/newborn mice by iodine contrastenhanced micro-CT showed this imaging modality is highly effective in identifying a wide spectrum of CHD. This is despite the intrinsic resolution limit (15-45 μm) of micro-CT relative to the small size of the newborn (<3.5 mm) and fetal (<2 mm) mouse hearts. Because micro-CT scan times are short (≈30 minutes), the rate-limiting step is the image processing required for reconstruction of the CT imaging data (≈4 hours). With the capability to simultaneously image 8 to 12 fetuses or pups per scan, CHD mutants can be readily identified from an entire litter with just 1 scan. This is cost effective and advantageous when examining multiple segregating genotypes in an entire litter of mice, or in high-throughput projects such as with forward genetic screens or large-scale phenotyping of knockout mice for functional gene annotation in KOMP2. 3, 4 We also noted micro-CT imaging can detect noncardiac defects, such as visceral organ situs anomalies, as well as craniofacial anomalies, brain defects, or other organ malformations (data not shown).
In this postgenomic era with the completion of human and mouse genome sequencing, there is great impetus for sophisticated high-throughput phenotyping methodologies to elucidate the genetic pathogenesis of human diseases. However, the success of phenotype-driven screens is contingent on having assays that are both high-throughput and with high detection sensitivity and specificity. Although necropsy and histopathology are the gold standard for confirming structural heart defect/disease diagnosis, 13 such analyses are not practical for large-scale screening and must be reserved for preselected animals deemed most likely to have defect phenotypes. Our study show micro-CT is well suited for such high-throughput screening for structural heart defect diagnosis. This can be invaluable for routine interrogation for CHD in mutant mouse models and in large-scale screens for the de novo recovery of CHD mouse mutants. In addition to micro-CT, several other imaging modalities have been adapted from their clinical counterparts for mouse cardiovascular phenotyping, such as high-frequency ultrasound 8, 9, [14] [15] [16] [17] and micro-MRI imaging. 18, 19 MRI is advantageous in that it has high soft tissue contrast that obviates the need for contrast enhancement, but MRI equipment is much more costly and image acquisition time is much longer (spanning 3-12 hours). In addition, training for MRI has a steeper learning curve. Another imaging modality to consider is high-frequency ultrasound. Ultrasound imaging, although ideally suited for CHD diagnosis, has the steepest learning curve. Thus unlike CT and MRI, CHD detection with ultrasonography requires clinical knowledge alterations in cardiac anatomy associated with CHD to guide manual manipulation of the ultrasound transducer during image acquisition. In contrast, MRI and CT scans are performed in a uniform manner with no clinical knowledge required, and the imaging data generated can later be evaluated by experienced clinicians.
Limitations
Although micro-CT imaging has high efficiency for identifying various structural cardiovascular defects, there are several limitations. In the present study, we used EFIC histopathology as the gold standard to confirm all CHD diagnoses. EFIC imaging provides image resolution at 0.1-μm voxel size, which compares favorably with fetal and newborn mouse hearts with 0.5-to 2-mm diameter (ventricular width). This is equivalent to using 40-μm voxel image resolution in imaging 40-mm diameter newborn human heart, 20 which should be sufficient for accurate diagnoses of cardiovascular structural defects. In contrast, the 15-to 45-μm voxel size used for micro-CT imaging in this study is equivalent to only a 1-to 1.3-mm voxel size in imaging the 40-mm diameter human heart. A, D, and G) , whereas heterotaxy pup exhibited dextrocardia, duplicated inferior vena cavae, left-pulmonary isomerism, normal liver lobation, and a left-sided stomach (C, F, and I). Arrows denote the direction to which the heart apex is pointing; asterisks indicate mirrored organ positioning. Scale bars=2.5 mm. Stm indicates stomach.
Of paramount importance for micro-CT diagnosis of CHD is the efficacy of contrast agent staining of soft tissue in the cardiovascular system. With poor contrast staining, not only were CHD diagnoses missed, but also imaging artifacts led to false diagnoses, such as VSDs or coronary artery fistulas. This underlies the difficulty with micro-CT detection of small interventricular septal defects, small vessels, and valvular defects. It also likely accounts for the inability to differentiate between CoA and IAA.
Conclusions
Contrast-enhanced micro-CT imaging of fetal/newborn mice provided >97% accuracy in the diagnosis of OFT defects, aortic arch anomalies, AVSD, tricuspid valve hypoplasia/atresia, and coronary artery fistulas. We observed lower accuracy for VSD (89.8%), which largely was attributable to difficulty in detection of very small VSDs, and erroneous VSD diagnoses attributable to imaging artifacts. OFT anomalies comprising persistent truncus arteriosus, DORV, or transposition of the great arteries can be readily differentiated by micro-CT imaging. The overall diagnostic sensitivity was >85% for all of the anomalies analyzed, except for coronary artery fistulas that were 50.0%. These findings show micro-CT is a robust imaging technique that can be used for high-throughput CHD phenotyping of fetal/newborn mice. 
